Cases 41 - 50 of 2,762
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-1405
Plaintiff:
REGENERON PHARMACEUTICALS, INC.
Defendant:
MYLAN PHARMACEUTICALS INC., BIOCON BIOLOGICS INC. and AMGEN USA, INC.
Acadia Pharmaceuticals Inc. v. Aurobindo Pharma Ltd.
as 24-1401
Plaintiff:
ACADIA PHARMACEUTICALS INC.
Defendant:
AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC., TEVA PHARMACEUTICALS USA, INC. and others
GALDERMA LABORATORIES, L.P. et al v. TARO PHARMACEUTICALS INC. et al
as 2:2024cv00333
Plaintiff:
GALDERMA LABORATORIES, L.P., GALDERMA S.A., GALDERMA RESEARCH & DEVELOPMENT, S.N.C. and others
Defendant:
TARO PHARMACEUTICALS INC., TARO PHARMACEUTICAL INDUSTRIES LTD. and TARO PHARMACEUTICALS U.S.A., INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GALDERMA LABORATORIES, L.P. et al v. TARO PHARMACEUTICALS INC. et al
as 3:2024cv00333
Plaintiff:
GALDERMA LABORATORIES, L.P., GALDERMA S.A., GALDERMA RESEARCH & DEVELOPMENT, S.N.C. and others
Defendant:
TARO PHARMACEUTICALS INC., TARO PHARMACEUTICAL INDUSTRIES LTD. and TARO PHARMACEUTICALS U.S.A., INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eagle Pharmaceuticals, Inc. v. Apotex Inc. et al
as 1:2024cv00064
Plaintiff:
Eagle Pharmaceuticals, Inc.
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eagle Pharmaceuticals, Inc. v. Baxter Healthcare Corporation
as 1:2024cv00066
Plaintiff:
Eagle Pharmaceuticals, Inc.
Defendant:
Baxter Healthcare Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC
as 1:2024cv00065
Plaintiff:
Eagle Pharmaceuticals, Inc.
Defendant:
Slayback Pharma LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc.
as 1:2024cv00050
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GALDERMA LABORATORIES, L.P. et al v. TEVA PHARMACEUTICALS, INC. et al
as 2:2024cv00197
Plaintiff:
GALDERMA LABORATORIES, L.P., GALDERMA S.A., GALDERMA RESEARCH & DEVELOPMENT, S.N.C. and others
Defendant:
TEVA PHARMACEUTICALS, INC., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS INTERNATIONAL GMBH and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Heron Therapeutics, Inc. v. Mylan Pharmaceuticals Inc.
as 1:2024cv00043
Plaintiff:
Heron Therapeutics, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
